Wednesday, 15 January, 2025
By TRN Online, Kathmandu, June 4: Permission has been granted for use of CoronaVac, a Chinese COVID-19 vaccine, manufactured by Sinovac life sciences company limited, in Nepal.
The Department of Drug Administration (DDA) granted the approval for the use of the vaccine today.
The DDA has already given permission for the use of Sinopharm COVID-19 vaccine (commonly understood as Vero Cell in Nepal), another Chinese COVID-19 vaccine, produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).
China has provided 1.8 million doses of Sinopharm COVID-19 vaccine as grant assistance to Nepal.
World Health Organisation (WHO) has listed both the COVID-19 vaccines for emergency use, giving the green light for these vaccines to be rolled out globally.
Do not make expressions casting dout on election: EC
14 Apr, 2022
CM Bhatta says may New Year 2079 BS inspire positive thinking
14 Apr, 2022
Three new cases, 44 recoveries in 24 hours
14 Apr, 2022
689 climbers of 84 teams so far acquire permits for climbing various peaks this spring season
14 Apr, 2022
How the rising cost of living crisis is impacting Nepal
14 Apr, 2022
US military confirms an interstellar meteor collided with Earth
14 Apr, 2022
Valneva Covid vaccine approved for use in UK
14 Apr, 2022
Chair Prachanda highlights need of unity among Maoist, Communist forces
14 Apr, 2022
Ranbir Kapoor and Alia Bhatt: Bollywood toasts star couple on wedding
14 Apr, 2022
President Bhandari confers decorations (Photo Feature)
14 Apr, 2022
